Icotinib With Whole Brain Radiation Therapy in NSCLC Patients With Brain Metastases

Clinical trial NCT01926171 · UNKNOWN

Trial details

NCT number: NCT01926171
Sponsor: Betta Pharmaceuticals Co., Ltd.
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Non-small-cell Lung Cancer

Start date: 2013-06-01
Primary completion: 2016-09-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.